[Clinical effects of L-dopa in Parkinson's disease].
D000284:Administration, Oral; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage*; D006801:Humans; D007275:Injections, Intravenous; D010276:Parasympatholytics / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy*
D010276:Parasympatholytics; D004295:Dihydroxyphenylalanine
Effetti clinici della L-dopa nella malattia di Parkinson.